Yersinia lead SUMO attack
- 1 January 2001
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 7 (1) , 21-23
- https://doi.org/10.1038/83298
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Disruption of Signaling by Yersinia Effector YopJ, a Ubiquitin-Like Protein ProteaseScience, 2000
- Assembly and Function of Type III Secretory SystemsAnnual Review of Microbiology, 2000
- The bacterial protein YopJ abrogates multiple signal transduction pathways that converge on the transcription factor CREBCellular Microbiology, 2000
- Ubiquitin-like proteins: new wines in new bottlesGene, 2000
- Inhibition of the Mitogen-Activated Protein Kinase Kinase Superfamily by a Yersinia EffectorScience, 1999
- The yopJ locus is required for Yersinia‐mediated inhibition of NF‐κB activation and cytokine expression: YopJ contains a eukaryotic SH2‐like domain that is essential for its repressive activityMolecular Microbiology, 1998
- Yersinia enterocolitica Impairs Activation of Transcription Factor NF-κB: Involvement in the Induction of Programmed Cell Death and in the Suppression of the Macrophage Tumor Necrosis Factor α ProductionThe Journal of Experimental Medicine, 1998
- YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF‐α production and downregulation of the MAP kinases p38 and JNKMolecular Microbiology, 1998
- Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector proteinProceedings of the National Academy of Sciences, 1997
- Recognition of the Bacterial Avirulence Protein AvrBs3 Occurs inside the Host Plant CellCell, 1996